As we saw tonight, the momentum exists to advance a national innovation agenda, one that stands to benefit millions of union members. But now comes the hard part: what can the administration and Members of Congress specifically do to translate this into new jobs and a higher quality of life for working Americans?
WASHINGTON, D.C.—Labor and management in the biopharmaceutical industry will “redouble efforts at the federal level to support increased protections to fight intellectual property theft, counterfeiting and piracy, along with real enforcement measures to implement those protections.”
Puerto Rico Law 154 would impose special taxes on non-resident individuals and companies operating in Puerto Rico. The law would be detrimental to the skilled men and women in Puerto Rico construction trades unions since this could lead to a decrease in local jobs and infrastructure investment.
Fred Mason, President of the Maryland AFL-CIO, wrote the following op-ed published in The Bowie Star regarding the emergence of the life sciences industry in Maryland and its far-reaching economic benefits.
William Burga, former President of the Ohio AFL-CIO, wrote the following op-ed published in The Cincinnati Enquirer detailing how the bioscience industry is responsible for roughly 92,000 jobs in Ohio and the importance of supporting research and training in the field.
Sam Latham, President of the Delaware AFL-CIO, wrote the following op-ed published in The News Journal in which he argues that while many of the manufacturing jobs in Delaware have dried up “the life sciences industry could help provide the steady, rewarding work —particularly the high-skilled union jobs — that so many folks in Delaware need.”